Evidence map›Paper›PMID 35330051›Full record

ArticleJournal of clinical medicine2022

Profile of Clinical and Analytical Parameters in Bronchiectasis Patients during the COVID-19 Pandemic: A One-Year Follow-Up Pilot Study.

Liyun Qin, Filipe Gonçalves-Carvalho, Yingchen Xia, Jianhua Zha, Mireia Admetlló, José María Maiques, Sandra Esteban-Cucó, Xavier Duran, Alicia Marín, Esther Barreiro

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Journal of clinical medicine, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.8field-weighted citation impact, top 29% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 6 citations in OpenAlex.

  1. Article
  2. Bronchiectasis in Adults: Aetiology and New Therapies.Journal of clinical medicine · 2022
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 6 institutions in 2 countries.

Liyun QinMuscle Wasting and Cachexia in Chronic Respiratory Diseases and Lung Cancer Research Group, Pulmonology Department, IMIM-Hospital del Mar, Parc de Salut Mar, Parc de Recerca Biomèdica de Barcelona (PRBB), 08003 Barcelona, Spain.
Filipe Gonçalves-CarvalhoPulmonology Department, Hospital Germans Trias i Pujol, 08916 Badalona, Spain.
Yingchen XiaMuscle Wasting and Cachexia in Chronic Respiratory Diseases and Lung Cancer Research Group, Pulmonology Department, IMIM-Hospital del Mar, Parc de Salut Mar, Parc de Recerca Biomèdica de Barcelona (PRBB), 08003 Barcelona, Spain.
Jianhua ZhaMuscle Wasting and Cachexia in Chronic Respiratory Diseases and Lung Cancer Research Group, Pulmonology Department, IMIM-Hospital del Mar, Parc de Salut Mar, Parc de Recerca Biomèdica de Barcelona (PRBB), 08003 Barcelona, Spain.
Mireia AdmetllóMuscle Wasting and Cachexia in Chronic Respiratory Diseases and Lung Cancer Research Group, Pulmonology Department, IMIM-Hospital del Mar, Parc de Salut Mar, Parc de Recerca Biomèdica de Barcelona (PRBB), 08003 Barcelona, Spain.ORCID 0000-0002-4315-5534
José María MaiquesRadiology Department, Imatge Mèdica Intercentres-Parc de Salut Mar, Hospital del Mar, 08003 Barcelona, Spain.
Sandra Esteban-CucóLaboratori de Referència de Catalunya, Clinical Microbiology and Parasitology Department, 08820 Barcelona, Spain.
Xavier DuranScientific and Technical Department, Hospital del Mar-IMIM, 08003 Barcelona, Spain.
Alicia MarínPulmonology Department, Hospital Germans Trias i Pujol, 08916 Badalona, Spain.ORCID 0000-0002-9358-2120
Esther BarreiroMuscle Wasting and Cachexia in Chronic Respiratory Diseases and Lung Cancer Research Group, Pulmonology Department, IMIM-Hospital del Mar, Parc de Salut Mar, Parc de Recerca Biomèdica de Barcelona (PRBB), 08003 Barcelona, Spain.
Instituto de Salud Carlos III · ESNanchang University · CNHospital Del Mar · ESParc de Salut · ESUniversitat Autònoma de Barcelona · ESUniversitat Pompeu Fabra · ES

Funding

Instituto de Salud Carlos III CIBERES 2021Instituto de Salud Carlos III FIS 21/00215Menarini SA Spain 2020Sociedad Española de Neumología y Cirugía Torácica SEPAR 2020Sociedad Española de Neumología y Cirugía Torácica SEPAR 698-2018
6 · The paper itself

Abstract

Whether the COVID-19 pandemic may have modified the clinical planning and course in bronchiectasis patients remains to be fully elucidated. We hypothesized that the COVID-19 pandemic may have influenced the management and clinical outcomes of bronchiectasis patients who were followed up for 12 months. In bronchiectasis patients (n = 30, 23 females, 66 years), lung function testing, disease severity [FEV

Indexed as

immunoglobulinslung functionnon-cystic fibrosis bronchiectasisnutritional statusone-year follow-upseverity scoressystemic inflammation and immunoglobulins

Identifiers

PMID35330051
PMCPMC8954272
OpenAlexW4220973452

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.